Scripps Research chemical biologist Benjamin Cravatt, PhD, has received a National Cancer Institute (NCI) Outstanding Investigator Award to support the development of advanced technologies for discovering and advancing new cancer targets and drugs.

The prestigious award, given to only a handful of scientists each year who have demonstrated particular promise and innovation in cancer research, will support the Cravatt laboratory with $7.8 million over seven years. 

“Having such a generous amount of funds for such an extended period is a huge opportunity and a huge relief, because it allows us to focus on the science—it’s a transformative opportunity for our research group,” says Cravatt, a professor and the Gilula Chair of Chemical Biology at Scripps Research.